Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Allogene Therapeutics, Inc. ALLO | VANGUARD GROUP INC | 7,265,221 5.040% | 7,265,221 (New Position) | Filing History |
| 2023-02-03 3:52 pm Purchase | 2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | STATE STREET CORP STT | 9,166,408 6.360% | 9,166,408 (New Position) | Filing History |
| 2023-02-03 12:09 pm Purchase | 2022-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | BlackRock Inc. BLK | 8,886,572 6.200% | 8,886,572 (New Position) | Filing History |
| 2022-04-07 4:11 pm Unchanged | 2022-03-31 | 13D | Allogene Therapeutics, Inc. ALLO | PFIZER INC PFE | 22,032,040 15.400% | 0 (Unchanged) | Filing History |
| 2022-02-14 5:20 pm Sale | 2021-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Seaview Trust | 7,041,120 4.940% | -299,747 (-4.08%) | Filing History |
| 2022-02-14 3:36 pm Purchase | 2021-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Belldegrun Arie | 7,203,248 5.000% | 708,755 (+10.91%) | Filing History |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Allogene Therapeutics, Inc. ALLO | Capital Research Global Investors | 0 0.000% | -12,640,338 (Position Closed) | Filing History |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | Allogene Therapeutics, Inc. ALLO | Capital International Investors | 1,728,252 1.200% | -5,971,451 (-77.55%) | Filing History |
| 2022-02-10 4:51 pm Sale | 2021-04-20 | 13G | Allogene Therapeutics, Inc. ALLO | GILEAD SCIENCES INC. GILD | 1,156,689 0.800% | -6,330,000 (-84.55%) | Filing History |
| 2022-01-18 4:50 pm Purchase | 2022-01-12 | 13D | Allogene Therapeutics, Inc. ALLO | TPG GP A LLC | 18,716,306 13.200% | 18,716,306 (New Position) | Filing History |
| 2021-09-17 4:17 pm Unchanged | 2021-09-10 | 13D | Allogene Therapeutics, Inc. ALLO | PFIZER INC PFE | 22,032,040 15.500% | 0 (Unchanged) | Filing History |
| 2021-02-16 4:04 pm Purchase | 2021-02-16 | 13G | Allogene Therapeutics, Inc. ALLO | Capital International Investors | 7,699,703 5.500% | 7,699,703 (New Position) | Filing History |
| 2021-02-16 3:46 pm Purchase | 2021-02-16 | 13G | Allogene Therapeutics, Inc. ALLO | Capital Research Global Investors | 12,640,338 9.000% | 6,097,660 (+93.20%) | Filing History |
| 2021-02-12 2:32 pm Sale | 2020-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Belldegrun Arie | 6,494,493 4.600% | -859,507 (-11.69%) | Filing History |
| 2021-02-12 1:00 pm Sale | 2020-12-31 | 13G | Allogene Therapeutics, Inc. ALLO | Seaview Trust | 7,340,867 5.200% | -1,251,741 (-14.57%) | Filing History |
| 2020-08-10 4:32 pm Sale | 2020-08-06 | 13D | Allogene Therapeutics, Inc. ALLO | TPG Group Holdings (SBS) Advisors Inc. | 18,716,306 13.400% | -1,000,000 (-5.07%) | Filing History |
| 2020-07-10 4:40 pm Sale | 2020-06-25 | 13D | Allogene Therapeutics, Inc. ALLO | TPG Group Holdings (SBS) Advisors Inc. | 19,716,306 14.200% | -1,500,000 (-7.07%) | Filing History |